Tag: ARCT

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has experienced a decline in its stock price by -8.26 compared to its previous closing price of 30.13. However,

Moreover, the 36-month beta value for ARCT is 2.61. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0